Frazier Life Sciences Management as of June 30, 2022
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 41 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 17.0 | $180M | 8.4M | 21.31 | |
| Hillevax (HLVX) | 9.6 | $102M | 9.3M | 10.93 | |
| Krystal Biotech (KRYS) | 6.8 | $72M | 1.1M | 65.66 | |
| Mirum Pharmaceuticals (MIRM) | 6.6 | $69M | 3.6M | 19.46 | |
| Chinook Therapeutics | 5.9 | $63M | 3.6M | 17.49 | |
| Syndax Pharmaceuticals (SNDX) | 5.8 | $62M | 3.2M | 19.24 | |
| Phathom Pharmaceuticals (PHAT) | 4.6 | $49M | 5.8M | 8.44 | |
| Sierra Oncology Com New | 4.5 | $48M | 871k | 54.99 | |
| Imago Biosciences | 3.8 | $40M | 3.0M | 13.39 | |
| Vaxcyte (PCVX) | 3.7 | $39M | 1.8M | 21.76 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.5 | $26M | 1.4M | 18.65 | |
| Tarsus Pharmaceuticals (TARS) | 2.5 | $26M | 1.8M | 14.60 | |
| Alpine Immune Sciences | 2.4 | $25M | 3.0M | 8.51 | |
| Tricida | 1.9 | $20M | 2.1M | 9.68 | |
| Cogent Biosciences (COGT) | 1.8 | $19M | 2.1M | 9.02 | |
| Anaptysbio Inc Common (ANAB) | 1.7 | $18M | 900k | 20.30 | |
| Gracell Biotechnologies Sponsored Ads | 1.6 | $17M | 3.1M | 5.50 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $16M | 1.6M | 9.84 | |
| Merus N V (MRUS) | 1.4 | $15M | 674k | 22.64 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 1.4 | $15M | 1.5M | 9.87 | |
| Replimune Group (REPL) | 1.3 | $14M | 806k | 17.48 | |
| Gritstone Oncology Ord (GRTSQ) | 1.2 | $13M | 5.2M | 2.42 | |
| Arvinas Ord (ARVN) | 1.1 | $12M | 285k | 42.09 | |
| Passage Bio (PASG) | 1.1 | $12M | 5.0M | 2.36 | |
| Miragen Therapeutics (VRDN) | 1.1 | $11M | 980k | 11.57 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.0 | $11M | 3.7M | 2.83 | |
| Intellia Therapeutics (NTLA) | 1.0 | $11M | 204k | 51.76 | |
| Silence Therapeutics Ads (SLN) | 1.0 | $10M | 881k | 11.85 | |
| Tyra Biosciences (TYRA) | 0.9 | $9.8M | 1.4M | 7.15 | |
| Sutro Biopharma (STRO) | 0.9 | $9.3M | 1.8M | 5.21 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $5.7M | 408k | 13.96 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.5 | $5.3M | 202k | 26.44 | |
| Trevi Therapeutics (TRVI) | 0.3 | $3.3M | 1.2M | 2.81 | |
| Pardes Biosciences | 0.2 | $2.6M | 846k | 3.07 | |
| Immunovant (IMVT) | 0.2 | $2.3M | 586k | 3.90 | |
| Essa Pharma Com New (EPIX) | 0.2 | $2.2M | 693k | 3.15 | |
| Iveric Bio | 0.2 | $1.6M | 170k | 9.62 | |
| Molecular Templates | 0.1 | $1.3M | 1.4M | 0.91 | |
| Epizyme | 0.1 | $1.1M | 739k | 1.47 | |
| Aptinyx | 0.1 | $1.1M | 1.9M | 0.56 | |
| Nabriva Therapeutics SHS | 0.0 | $77k | 426k | 0.18 |
